MEDICUS PHARMA LTD. Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax
MEDICUS PHARMA LTD. (MDCX) reported Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax of $255.18 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax · last filed 2026-08-12
- MEDICUS PHARMA LTD. other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax for the quarter ending 2026-06-30 was $255.18K.
- MEDICUS PHARMA LTD. other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax for the quarter ending 2025-06-30 was $0.00.
| Period end | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax 3 month | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax 6 month |
|---|---|---|
| 2026-06-30 | $255.18K 10-Q · filed 2026-08-12 | $50.93K 10-Q · filed 2026-08-12 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-12 | $0.00 10-Q · filed 2026-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |